- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Patients With Multiple Sclerosis in New Zealand
Total 580 results
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Croatia, Russian Federation, India, Spain, New Zealand, Canada, Belgium, Netherlands, Bulgaria, Serbia, Greece, Ukraine, Mexico, Georgia, Colombia, Germany, Poland, United Kingdom, Czech Republic, France, Chile, Romania, Eston... and more
-
BiogenCompleted
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminatedRelapsing Multiple SclerosisSweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
-
MedImmune LLCCompletedMultiple Sclerosis, Relapsing FormsUnited States, Spain, Poland, Ukraine
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
CelgeneCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States, Germany
-
MallinckrodtMallinckrodt ARD Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
EMD SeronoTerminatedRelapsing Multiple SclerosisUnited States, Sweden, Australia, Czech Republic, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Ukraine, Netherlands, Canada, France, Austria, Lebanon, Switzerland, Belgium
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States, Italy, Switzerland, Canada, Australia, Germany, Spain, France, Portugal, Netherlands, United Kingdom, Denmark, Austria, Ireland
-
BiogenRecruitingRelapsing Forms of Multiple SclerosisSpain, United States, Italy, Switzerland, Germany, Bulgaria, Czechia, Poland, Puerto Rico, Romania
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
Suhayl Dhib-Jalbut, MDEnrolling by invitation
-
Rutgers, The State University of New JerseyBayerCompletedMultiple SclerosisUnited States
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisUnited States, Poland, Austria, Belgium, Czechia, Germany, Australia, Switzerland, Lebanon, Argentina, Canada, Slovenia, Bulgaria, Latvia, Russian Federation, Spain, Italy, Turkey, Slovakia, Portugal, Greece, Saudi Arabia, Hungary, No... and more
-
Opexa Therapeutics, Inc.TerminatedClinically Isolated Syndrome | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Hospital for Special Surgery, New YorkRecruitingPatients With Spinal Stenosis Indicated for MIS TLIFUnited States
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisUnited States, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, Sweden, United States, France, Switzerland, Ireland, Canada, Australia, Brazil, Austria, Poland, Germany, Hungary, Netherlands, Russian Federation, Spain, Argentina, Slovenia, Greece, Finland, Denmark, Ukraine, Italy, L... and more
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Brazil, Poland, United Kingdom, Turkey, Bulgaria, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Mexico, Argentina
-
Kessler FoundationInstituto Vocacional Enrique Díaz de León A.C., Guadalajara, MexicoRecruitingTBI (Traumatic Brain Injury) or MS (Multiple Sclerosis)United States, Spain
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
Hunter College of City University of New YorkRecruiting
-
Icahn School of Medicine at Mount SinaiDoris Duke Charitable FoundationRecruiting
-
Tisch Multiple Sclerosis Research Center of New...CompletedMultiple SclerosisUnited States
-
Tisch Multiple Sclerosis Research Center of New...No longer available
-
NYU Langone HealthNational Multiple Sclerosis SocietyCompleted
-
Weill Medical College of Cornell UniversityMallinckrodtTerminatedMultiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
Tisch Multiple Sclerosis Research Center of New...Completed
-
BiogenCompleted
-
BiogenElan PharmaceuticalsCompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingUnited States, Germany, Austria, Belgium, France, Israel, Italy
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
University of California, San FranciscoMassachusetts General Hospital; Mayo Clinic; Baylor College of Medicine; Children... and other collaboratorsCompletedPediatric Multiple SclerosisUnited States
-
SanofiActive, not recruitingRelapsing Multiple SclerosisUnited States, Argentina, Belgium, Brazil, Canada, Chile, Croatia, Czechia, France, Germany, Greece, Hungary, India, Israel, Korea, Republic of, Latvia, Netherlands, Norway, Portugal, Puerto Rico, Russian Federation, Serbia, Slovakia, Spai... and more
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisBelgium, Italy, United States, Croatia, Spain, Netherlands, Switzerland, Thailand, Israel, Czechia, Estonia, Poland, France, Bulgaria, Russian Federation, Germany, Turkey, Slovakia, Australia, Denmark, Greece, Argentina, India, Hungary, United Kingdom and more
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
Genentech, Inc.Roche Pharma AGCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada, Belgium, Spain, France, Switzerland, Ukraine, Mexico, Germany, Bulgaria, United Kingdom, Romania, Czechia, Italy, Russian Federation, Serbia, Slovakia, Denmark
-
Fred LublinPfizer; National Multiple Sclerosis SocietyTerminatedMultiple SclerosisUnited States
-
Hunter College of City University of New YorkRecruiting